Andrew Hykes - 10 Feb 2025 Form 4 Insider Report for Inari Medical, Inc.

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Issuer symbol
N/A
Transactions as of
10 Feb 2025
Net transactions value
+$184,569
Form type
4
Filing time
12 Feb 2025, 16:42:56 UTC
Previous filing
06 Feb 2025
Next filing
19 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Options Exercise $69,015 +161,100 +32% $0.4284 663,806 10 Feb 2025 Direct
transaction NARI Common Stock Options Exercise $107,914 +16,719 +2.5% $6.45 680,525 10 Feb 2025 Direct
transaction NARI Common Stock Options Exercise $7,639 +16,719 +2.5% $0.4569 697,244 10 Feb 2025 Direct
holding NARI Common Stock 1,550 10 Feb 2025 By Child 1
holding NARI Common Stock 1,550 10 Feb 2025 By Child 2
holding NARI Common Stock 1,550 10 Feb 2025 By Child 3
holding NARI Common Stock 1,000 10 Feb 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NARI Stock Options (Right to Buy) Options Exercise $0 -161,100 -100% $0.000000 0 10 Feb 2025 Common Stock 161,100 $0.4284 Direct F1
transaction NARI Stock Option Options Exercise $0 -16,719 -100% $0.000000 0 10 Feb 2025 Common Stock 16,719 $6.45 Direct F2
transaction NARI Stock Option Options Exercise $0 -16,719 -100% $0.000000 0 10 Feb 2025 Common Stock 16,719 $0.4569 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option became fully vested and exercisable as of March 29, 2022.
F2 The option became fully vested and exercisable as of January 1, 2024.
F3 The option became fully vested and exercisable as of January 1, 2023.